CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Current Assets:
Cash and cash equivalents	$ 3,910	$ 4,237
Marketable Securities, Current	2,199	2,113
Receivables	5,494	5,543
Inventories	1,384	1,241
Prepaid expenses and other	628	570
Total Current Assets	13,615	13,704
Property, plant and equipment	5,020	4,980
Goodwill	6,875	6,875
Other intangible assets	1,276	1,385
Deferred income taxes	2,618	2,996
Marketable Securities, Noncurrent	2,685	2,719
Other assets	848	1,048
Total Assets	32,937	33,707
Current Liabilities:
Short-term debt obligations	1,197	992
Accounts payable	1,503	1,664
Accrued liabilities	4,777	5,271
Deferred income	837	762
Income taxes payable	180	152
Total Current Liabilities	8,494	8,841
Deferred income	528	547
Income taxes payable	948	973
Pension and other liabilities	1,195	1,283
Long-term debt	7,237	5,716
Total Liabilities	18,402	17,360
Commitments and contingencies (Note 17)
Bristol-Myers Squibb Company Shareholders' Equity:
Preferred stock	0	0
Common stock	221	221
Capital in excess of par value of stock	1,337	1,725
Accumulated other comprehensive loss	(2,414)	(2,503)
Retained earnings	33,658	33,513
Less cost of treasury stock	(18,386)	(16,779)
Total Bristol-Myers Squibb Company Shareholders' Equity	14,416	16,177
Noncontrolling interest	119	170
Total Equity	14,535	16,347
Total Liabilities and Equity	$ 32,937	$ 33,707